DXS International is quoted on the Aquis Stock Exchange Growth Market under the code DXSP. The company describes itself as a digital clinical decision support business, providing treatment guidelines and guidance to healthcare professionals during patient consultations. Its products include SMART Referral software and …
Moderna (NASDAQ:MRNA) shares rallied on Friday after the biotechnology company was flagged to join the Nasdaq-100 index. The inclusion is set to take effect before the open on 9 October 2026, and the prospect of that change was the confirmed catalyst for the move. …
● No clinical-trial result, regulatory decision, financing disclosure,Partnershipannouncement or analyst rating change could be reliably dated to the session.
● Voyager Therapeutics closed at $2.45 on Friday, October 2, 2026, a decline of 8.41% on the session.
● No press release, regulatory update, clinical disclosure or corporate announcement tied to the session could be confirmed from available sources.
● No clinical-trial result, regulatory decision, financing or analyst action could be tied to the session to explain the move.
● No clinical readout, regulatory decision, partnership, financing orEarningsevent was identified for October 2 to account for the gain.
● NoEarningsrelease, test launch, reimbursement decision or analyst action could be tied to the session.
● No clinical-trial result, regulatory decision, licensing orPartnershipannouncement, management change or analyst action could be dated to the session.
● Anbio Biotechnology closed at $5.55 on Friday, October 2, 2026, a decline of 11.77% on the session.